周五盘中，ANI制药（股票代码：ANIP）股价大涨16.95%，引起市场广泛关注。这一显著涨幅主要源于该公司公布的最新季度财报远超分析师预期。
根据ANI制药发布的财报，截至3月31日的季度调整后每股收益达到1.80美元，大幅超越分析师平均预期的1.42美元，同时也高于去年同期的1.21美元。公司营收同比增长53.8%，达到2.1137亿美元，同样超过分析师预期的1.9029亿美元。这一亮眼业绩表现无疑是推动股价飙升的主要动力。
值得注意的是，华尔街分析师对ANI制药的前景持积极态度。目前，分析师对该公司股票的平均评级为"买入"，12个月目标价中位数为84.00美元，较上一交易日收盘价高出约17.8%。这种乐观情绪进一步支撑了投资者的信心，促使更多资金涌入，推动股价上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.